Open AccessPROPHYLAXIS OF MALARIA
Author(s) -
Eli Schwartz
Publication year - 2012
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2012.045
Subject(s) - primaquine , chemoprophylaxis , malaria , medicine , malaria prophylaxis , vivax malaria , plasmodium falciparum , intensive care medicine , immunology , plasmodium vivax , pediatrics , chloroquine
Malaria prevention in travelers to endemic areas remains dependent principally on chemoprophylaxis. Although malaria chemoprophylaxis refers to all malaria species, a distinction should be drawn between falciparum malaria prophylaxis and the prophylaxis of the relapsing malaria species (vivax & ovale). While the emergence of drug resistant strains, as well as the costs and adverse reactions to medications, complicate falciparum prophylaxis use, there are virtually no drugs available for vivax prophylaxis, beside of primaquine. Based on travelers malaria data, a revised recommendation for using chemoprophylaxis in low risk areas should be considere